$HEPA

$0.09 +$0.02 (33.33%) Close

$HEPA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 90.2M shares outstanding

Who owns HEPA?

By type of holder

Institutions 0.0% Insiders 100.0% Everyone else 0.0%

Concentration Top 10 holders own 126.6%

Vincent LoPriore 29.1% · Gravitas Collective Corp. 27.7%

Institutional ownership

0.0%

0.0 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

by institutions in Q2 2026

New / sold out

0 / 0

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Hepion Pharmaceuticals Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2023–FY2025

+11748.2%

+988.49% a year

Each share's claim on the business

−99.2%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $2.15M

over 3 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years0% Under 1 year100%

Quarterly turnover

0.0%

of institutional shares changed hands

Top 10 managers, median time held

3 quarters

Super Investors

Investment managers reporting HEPA on Form 13F

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
AA Ancora Advisors LLC	1	0.00%	Unchanged		Q3 '25	0.0%
Shares held by quarter Peak holding1 (Q3'25) Change over 8 quarters+1 Share of the company0.000% Ancora Advisors LLC's full portfolio →

Ancora Advisors LLC

% of company

0.00%

Change vs last qtr

Unchanged

Held since

Q3 '25

Institutional Funds

Mutual funds and ETFs reporting HEPA on Form N-PORT; together they hold 0.1% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$27.2K	40.7K	0.05%	0.00%	September 30, 2024
FE Fidelity Extended Market Index Fund Fidelity Concord Street Trust	$3.97K	31.5K	0.03%	0.00%	February 28, 2025

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$27.2K

% of company

0.05%

% of the fund

0.00%

As of

September 30, 2024

Fidelity Extended Market Index Fund

Fidelity Concord Street Trust

Position value

$3.97K

% of company

0.03%

% of the fund

0.00%

As of

February 28, 2025

4 more funds behind a free account

See every fund holding Hepion Pharmaceuticals Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
VL Vincent LoPriore 5%+ holder 13D · 26.2%	26.3M	29.10%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company29.100% Disclosed stake13D · 26.2% View the 13D/G filing →
GC Gravitas Collective Corp. 5%+ holder 13D · 19.9%	25.0M	27.71%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company27.710% Disclosed stake13D · 19.9% View the 13D/G filing →

Vincent LoPriore

5%+ holder13D · 26.2%

26.3M

% of company

29.10%

Change vs last qtr

—

Held since

—

Gravitas Collective Corp.

5%+ holder13D · 19.9%

25.0M

% of company

27.71%

Change vs last qtr

—

Held since

—

8 more holders behind a free account

See every insider and 5%+ holder of Hepion Pharmaceuticals Inc.

Comments